TMED vs. TCHP

Last updated Jun 4, 2026

TMED (T. Rowe Price Health Care ETF) and TCHP (T. Rowe Price Blue Chip Growth ETF) are both exchange-traded funds - TMED is a Health & Biotech Equities fund managed by T. Rowe Price, while TCHP is a Large Cap Growth Equities fund actively managed by T. Rowe Price. At a 0.30 correlation, their price movements are largely independent. TMED charges 0.44%/yr vs 0.57%/yr for TCHP.

Performance

TMED vs. TCHP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in T. Rowe Price Health Care ETF (TMED) and T. Rowe Price Blue Chip Growth ETF (TCHP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both investments are quite close, with TMED having a 3.87% return and TCHP slightly higher at 3.99%.

TMED

• 1D: 1.04%
• 1M: 2.47%
• YTD: 3.87%
• 6M: 4.17%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

TCHP

• 1D: -1.29%
• 1M: 3.68%
• YTD: 3.99%
• 6M: 4.18%
• 1Y: 20.05%
• 3Y*: 24.50%
• 5Y*: 11.66%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

TMED vs. TCHP - Yearly Performance Comparison

	2026 (YTD)	2025
TMED T. Rowe Price Health Care ETF	3.87%	18.92%
TCHP T. Rowe Price Blue Chip Growth ETF	3.99%	14.04%

Correlation

The correlation between TMED and TCHP is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Jun 13, 2025	0.30

Return for Risk

TMED vs. TCHP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TCHP

TCHP Risk / Return Rank: 30
TCHP Sharpe Ratio Rank: 34
TCHP Sortino Ratio Rank: 32
TCHP Omega Ratio Rank: 32
TCHP Calmar Ratio Rank: 24
TCHP Martin Ratio Rank: 27

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TMED vs. TCHP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and T. Rowe Price Blue Chip Growth ETF (TCHP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	TMED	TCHP	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.25	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.50	—
Sharpe Ratio (All Time) Calculated using the full available price history	1.35	0.57	+0.78

Drawdowns

TMED vs. TCHP - Drawdown Comparison

The maximum TMED drawdown since its inception was -11.11%, smaller than the maximum TCHP drawdown of -42.34%. Use the drawdown chart below to compare losses from any high point for TMED and TCHP.

Drawdown Indicators

	TMED	TCHP	Difference
Max Drawdown Largest peak-to-trough decline	-11.11%	-42.34%	+31.23%
Max Drawdown (1Y) Largest decline over 1 year	—	-17.50%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-22.92%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-42.34%	—
Current Drawdown Current decline from peak	-2.75%	-2.21%	-0.54%
Average Drawdown Average peak-to-trough decline	-2.59%	-11.47%	+8.88%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	5.23%	—

Volatility

Volatility by Period

	TMED	TCHP	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	3.84%	—
Volatility (6M) Calculated over the trailing 6-month period	—	12.20%	—
Volatility (1Y) Calculated over the trailing 1-year period	18.04%	16.12%	+1.92%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.04%	23.43%	-5.39%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.04%	23.18%	-5.14%

TMED vs. TCHP - Expense Ratio Comparison

TMED has a 0.44% expense ratio, which is lower than TCHP's 0.57% expense ratio.

Dividends

TMED vs. TCHP - Dividend Comparison

TMED's dividend yield for the trailing twelve months is around 0.52%, while TCHP has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021
TCHP T. Rowe Price Blue Chip Growth ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.02%
TMED T. Rowe Price Health Care ETF	0.52%	0.54%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both TMED and TCHP in my portfolio?

TMED and TCHP have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, TMED or TCHP?

On fees, TMED is cheaper at 0.44% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, TMED or TCHP?

TMED is cheaper with a 0.44% expense ratio, compared with 0.57% for TCHP.

Which ETF pays a higher dividend yield, TMED or TCHP?

TMED has the higher dividend yield at 0.52%, compared with 0.00% for TCHP.

What is the main difference between TMED and TCHP?

TMED is categorized as Health & Biotech Equities, while TCHP is Large Cap Growth Equities. Their fees differ too: 0.44% for TMED and 0.57% for TCHP.